NATIONAL CANCER DRUG FUND PRIORITISATION SCORES Drug Indication PONATINIB

First Page		Document Content
Date: 2013-10-01 10:55:28 Medicine Piperazines Organofluorides Pyrimidines Pyridines Chronic myelogenous leukemia Dasatinib Ponatinib Nilotinib Organic chemistry Chemistry Orphan drugs		NATIONAL CANCER DRUG FUND PRIORITISATION SCORES Drug Indication PONATINIB Add to Reading List Source URL: www.england.nhs.uk Download Document from Source Website File Size: 284,25 KB Share Document on Facebook

	Case 3:16-cvDocument 1 FiledPage 1 ofDorian S. Berger, CA State Bar NoDaniel P. Hipskind, CA State Bar No DocID: 1rqYi - View Document
	Microsoft WordDOCX DocID: 1rnqZ - View Document
	Beilage 1: Arzneimittelmonographien DocID: 1rinj - View Document
	SAFETY DATA SHEET Page 1 of Total 6 Date of Issue: August 2016 SDS No. FMC/RAD/1 SECTION 1 DocID: 1rdYu - View Document
	imatinib and colon cancer. imatinib availability imatinib and cml imatinib and tight junction cancer imatinib prostate dercum and imatinib zactima plus imatinib DocID: 1rdbp - View Document